Both Ozempic and Mounjaro are approved by the FDA to treat Type 2 diabetes, but some doctors prescribe the medication ...

People who received weekly injections of semaglutide -- the active agent in the diabetes drug Ozempic and the weight-loss ...

The diabetes and weight loss medications Ozempic and Wegovy are now considered to be available after more than two years of ...

It is a sign that Novo Nordisk’s efforts to ramp up the supply of those drugs are starting to pay off, as demand continues to ...

After years in shortage, weight loss and diabetes drugs Ozempic and Wegovy are now considered to be “available” by the Food ...

New research shows that weight loss drugs semaglutide, known as Ozempic and Wegovy, not only aid in weight loss but also ...

The results of a clinical trial published this week found that the active ingredient in the diabetes and weight loss ...

All doses of the two drugs are now listed as available in the U.S., per an FDA database, although the company cautioned ...

Semaglutide, the scientific name for Novo’s GLP-1 diabetes drug Ozempic and obesity drug Wegovy, has been on the shortage ...

All doses of Novo Nordisk’s (NVO) diabetes and obesity treatments are listed as available on the FDA’s drug shortage list as of ...

With the cost of GLP-1s rising for employers, so-called compounded weight-loss drugs have emerged as a more cost-conscious ...